187 related articles for article (PubMed ID: 28505675)
1. [Anti(lymph)angiogenic Strategies to Improve Corneal Graft Survival].
Bock F; Cursiefen C
Klin Monbl Augenheilkd; 2017 May; 234(5):674-678. PubMed ID: 28505675
[TBL] [Abstract][Full Text] [Related]
2. [Anti(lymph)angiogenic preconditioning prior to keratoplasty].
Cursiefen C; Regenfuss B; Hos D; Bucher F; Steven P; Heindl LM; Bock F
Klin Monbl Augenheilkd; 2013 May; 230(5):500-4. PubMed ID: 23695846
[TBL] [Abstract][Full Text] [Related]
3. VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation.
Dohlman TH; Omoto M; Hua J; Stevenson W; Lee SM; Chauhan SK; Dana R
Transplantation; 2015 Apr; 99(4):678-86. PubMed ID: 25606789
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival.
Hou Y; Bock F; Hos D; Cursiefen C
Cells; 2021 Jul; 10(7):. PubMed ID: 34359831
[TBL] [Abstract][Full Text] [Related]
5. Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival.
Le VNH; Schneider AC; Scholz R; Bock F; Cursiefen C
Sci Rep; 2018 Apr; 8(1):5707. PubMed ID: 29632336
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.
Hajrasouliha AR; Funaki T; Sadrai Z; Hattori T; Chauhan SK; Dana R
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1244-50. PubMed ID: 22281820
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
8. Semaphorin 3F Modulates Corneal Lymphangiogenesis and Promotes Corneal Graft Survival.
Reuer T; Schneider AC; Cakir B; Bühler AD; Walz JM; Lapp T; Lange C; Agostini H; Schlunck G; Cursiefen C; Reinhard T; Bock F; Stahl A
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5277-5284. PubMed ID: 30383199
[TBL] [Abstract][Full Text] [Related]
9. Subconjunctivally applied naïve Tregs support corneal graft survival in baby rats.
Hildebrand A; Jarsch C; Kern Y; Böhringer D; Reinhard T; Schwartzkopff J
Mol Vis; 2014; 20():1749-57. PubMed ID: 25558177
[TBL] [Abstract][Full Text] [Related]
10. Rejection and acceptance of corneal allografts.
Klebe S; Coster DJ; Williams KA
Curr Opin Organ Transplant; 2009 Feb; 14(1):4-9. PubMed ID: 19337139
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.
Hos D; Bachmann B; Bock F; Onderka J; Cursiefen C
Exp Eye Res; 2008 Nov; 87(5):427-32. PubMed ID: 18755186
[TBL] [Abstract][Full Text] [Related]
12. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology.
Cursiefen C; Chen L; Dana MR; Streilein JW
Cornea; 2003 Apr; 22(3):273-81. PubMed ID: 12658100
[TBL] [Abstract][Full Text] [Related]
13. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.
Bock F; Maruyama K; Regenfuss B; Hos D; Steven P; Heindl LM; Cursiefen C
Prog Retin Eye Res; 2013 May; 34():89-124. PubMed ID: 23348581
[TBL] [Abstract][Full Text] [Related]
14. Lymphatic vessels in the development of tissue and organ rejection.
Hos D; Cursiefen C
Adv Anat Embryol Cell Biol; 2014; 214():119-41. PubMed ID: 24276891
[TBL] [Abstract][Full Text] [Related]
15. The atypical chemokine receptor-2 does not alter corneal graft survival but regulates early stage of corneal graft-induced lymphangiogenesis.
Yu T; Forrester JV; Graham GJ; Kuffova L
Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):1875-1882. PubMed ID: 30054731
[TBL] [Abstract][Full Text] [Related]
16. UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial.
Wiedemann J; Hos D; Limburg E; Zettelmeyer U; Schiller P; Franklin J; Bachmann B; Böhringer D; Dietrich-Ntoukas T; Fuchsluger TA; Geerling G; Lang SJ; Mayer WJ; Priglinger S; Reinhard T; Seitz B; Cursiefen C
Trials; 2024 Mar; 25(1):169. PubMed ID: 38448965
[TBL] [Abstract][Full Text] [Related]
17. Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation.
Bachmann BO; Luetjen-Drecoll E; Bock F; Wiegand SJ; Hos D; Dana R; Kruse FE; Cursiefen C
Br J Ophthalmol; 2009 Aug; 93(8):1075-80. PubMed ID: 19224901
[TBL] [Abstract][Full Text] [Related]
18. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
[TBL] [Abstract][Full Text] [Related]
19. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.
Maruyama K; Nakazawa T; Cursiefen C; Maruyama Y; Van Rooijen N; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3145-53. PubMed ID: 22511631
[TBL] [Abstract][Full Text] [Related]
20. Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survival.
Zhang W; Schönberg A; Hamdorf M; Georgiev T; Cursiefen C; Bock F
Br J Ophthalmol; 2022 Nov; 106(11):1617-1626. PubMed ID: 34810177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
